VOLITIONRX LTD (VNRX) Form S-3/A — Sep 8, 2026
VolitionRx filed Pre-Effective Amendment No. 2 to its Form S-3, registering up to 10,006,360 shares of common stock for resale by selling stockholder Lind Global Asset Management XII LLC, issuable upon conversion and/or repayment of two secured convertible notes issued in May 2025 and January 2026. VolitionRx receives no proceeds from any sales and bears roughly $31,539 in registration expenses.
Key figures
- Shares Offered
- 10006360
- Atm Capacity Usd
- 30000000
- Reverse Split Ratio
- 1-for-20
- Shares Outstanding
- 18727948
- Warrant Shares2025
- 651042
- Warrant Shares2026
- 350018
- Warrant Exercise Price
- 2.015
- Last Reported Sale Price
- 0.33
- June2026 Offering Shares
- 2960000
- Atm Shares Sold Since Jun30
- 3897952
- Conversion Price2026 Note
- 1.55
- Atm Net Proceeds Since Jun30
- 2121146
- Authorized Shares Reduction
- 325,000,000 to 150,000,000
- Note2025 Original Principal
- 7500000
- Note2026 Original Principal
- 2400000
- Registration Expenses Total
- 31539
- Atm Gross Proceeds Since Jun30
- 2175581
- Market Cap Covenant Threshold
- 22500000
- June2026 Offering Net Proceeds
- 4100000
- Note2025 Outstanding Principal
- 4216666
- Note2026 Outstanding Principal
- 2640000
- June2026 Offering Warrant Shares
- 1480000
- Lind Beneficial Ownership Shares
- 12434859
- Lind Beneficial Ownership Percent
- 4.99%
- Covenant Penalty Principal Increase
- 623333
- Previously Registered Resale Shares
- 4327440
Price after filing
1 day: +2.9%7 days: -12.9%30 days: -32.0%
Close on the filing date to close N calendar days later (from $0.33). Historical, not a forecast.
AI analysis
Red flags8 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.